MedTrace Logo

Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression

NCT04803071 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2021-03-17

No results posted yet for this study

Summary

The aim of this study was to evaluate the effect of n-3pufas on cognitive function in patients with depression

Conditions

Interventions

DIETARY_SUPPLEMENT

Experimental group of n-pufas improving cognitive formula

Three times a day, one capsule of n-3pufas improvement cognitive formula capsule (once in the morning, in the evening) and routine treatment for depression, lasting for 12 weeks

DIETARY_SUPPLEMENT

General fish oil formula product adjuvant treatment control group

The control group: 1 capsule of general fish oil formula (once in the morning, in the evening) three times a day, plus routine treatment for depression, lasting for 12 weeks

DIETARY_SUPPLEMENT

Placebo assisted treatment group

Three times a day, one capsule of placebo adjuvant therapy (once in the morning, one in the evening) and conventional treatment of depression for 12 weeks

Sponsors & Collaborators

  • Guangzhou Psychiatric Hospital

    lead OTHER_GOV

Principal Investigators

  • kangguang Lin, PHD,MD · Guangzhou Psychiatric Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-10-01
Completion
2022-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04803071 on ClinicalTrials.gov